Table 1. Demographic and clinical characteristics of patients hospitalized with infectious mononucleosis and of healthy controls.
Sample | Age | Sex | Days from onset | Fever(°C) | VCA IgM(UI/ml) | VCA IgG(UI/ml) | EBNA-1 IgG(UI/ml) | EAIgG(UI/ml) | EBVDNAa |
IM-1 | 18 | M | 5 | 38.5 | >160 | 80 | neg | 115 | <185 |
IM-2 | 23 | F | 8 | 40 | >160 | 126 | neg | blb | neg |
IM-3 | 19 | F | 9 | 38.5 | 106 | neg | neg | neg | ndc |
IM-4 | 20 | F | 10 | 39 | >160 | 146 | neg | >150 | nd |
IM-5 | 23 | F | 10 | 37.5 | >160 | 35 | neg | bl | neg |
IM-6 | 32 | F | 10 | 38 | >160 | 33 | bl | neg | 5,725 |
IM-7 | 22 | F | 10 | 37.5 | 83 | 119 | neg | 104 | nd |
IM-8 | 22 | F | 12 | 39 | >160 | 195 | bl | 69 | neg |
IM-9 | 23 | M | 12 | 39 | 115 | 231 | neg | >150 | 1,685 |
IM-10 | 23 | F | 15 | 38.5 | 49 | 21 | neg | neg | 225 |
IM-11 | 21 | F | 16 | 38 | >160 | 58 | bl | 65 | <185 |
IM-12 | 14 | F | 17 | 39 | >160 | 108 | neg | >150 | 180 |
IM-13 | 22 | F | 18 | 38 | Pos | pos | pos | bl | nd |
IM-14 | 27 | M | 19 | 38.5 | >160 | 58 | neg | 54 | 401 |
IM-15 | 19 | F | 23 | 38.2 | >160 | neg | neg | neg | nd |
IM-16 | 40 | M | 37 | 39.5 | 95 | neg | neg | neg | neg |
IM-17 | 27 | F | 55 | 37.5 | >160 | 345 | >600 | >150 | neg |
HD-1 | 20 | F | – | – | Neg | neg | neg | neg | nd |
HD-2 | 21 | F | – | – | Neg | neg | neg | neg | nd |
HD-3 | 22 | F | – | – | Neg | neg | neg | neg | nd |
HD-4 | 23 | F | – | – | Neg | neg | neg | neg | nd |
HD-5 | 23 | F | – | – | Neg | neg | neg | neg | nd |
HD-6 | 27 | F | – | – | Neg | neg | neg | neg | nd |
HD-7 | 31 | F | – | – | Neg | neg | neg | neg | nd |
HD-8 | 31 | M | – | – | Neg | neg | neg | neg | nd |
HD-9 | 32 | F | – | – | Neg | neg | neg | neg | nd |
HD-10 | 20 | M | – | – | Neg | 483 | 157 | neg | nd |
HD-11 | 21 | M | – | – | Neg | 137 | 246 | neg | nd |
HD-12 | 23 | F | – | – | Neg | 158 | 48 | nd | nd |
HD-13 | 23 | F | – | – | Neg | 143 | 142 | neg | nd |
HD-14 | 26 | M | – | – | Neg | nd | <600 | nd | nd |
HD-15 | 28 | M | – | – | Neg | 81,3 | 289 | neg | nd |
HD-16 | 29 | F | – | – | Neg | nd | <600 | nd | nd |
HD-17 | 23 | F | – | – | Neg | nd | >600 | nd | nd |
HD-18 | 23 | F | – | – | Neg | nd | >600 | nd | nd |
HD-19 | 25 | F | – | – | Neg | >750 | >600 | neg | nd |
HD-20 | 26 | M | – | – | Neg | >750 | >600 | neg | nd |
HD-21 | 29 | F | – | – | Neg | >750 | >600 | neg | nd |
HD-22 | 29 | M | – | – | Neg | 176 | >600 | neg | nd |
HD-23 | 35 | F | – | – | Neg | neg | >600 | neg | nd |
HD-24 | 39 | M | – | – | Neg | nd | >600 | nd | nd |
data are expressed as EBNA-1 DNA copies/ml of plasma. Detection limits: 100 copies/ml of plasma;
bl, borderline;
not done.